Trough levels of ipilimumab in serum as a potential biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab
oleh: William L Redmond, Walter J Urba, John Cha, Yoshinobu Koguchi, Brendan D Curti, Noriko Iwamoto, Takashi Shimada, Shu-Ching Chang, Brian D Piening
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-10-01 |
Deskripsi
No description available for this item.